abstract |
The present invention provides pharmaceutical formulations of anti-CGRP antibodies and methods of using the same, which are suitable for use as migraine, paroxysmal headaches, chronic headaches, chronic cluster headaches, and paroxysmal cluster headaches Treatment. |